States Continue To Pursue And Expand Healthcare Market Oversight, With Significant Implications For Private Equity

In recent years, states have shown an increased interest in regulating healthcare markets. The trend has accelerated further since the start of 2025, with a flurry of proposals in at least 12 states. Some of these proposed laws specifically aim to regulate private equity investment in healthcare, and all of these draft laws would profoundly affect the way private equity currently does business if passed in their current form. For regulated parties, this increase […]

By | March 19th, 2025 ||

False Claims Act Enforcement In Health Care And Life Sciences, Part I

Earlier this year, the Department of Justice (“DOJ”) announced the results of its 2023 False Claims Act (“FCA”) enforcement efforts. Through those efforts, the government obtained more than $2.6 billion in overall recoveries, and of that amount, $1.8 billion came from health care and life sciences (“HCLS”) stakeholders alone.

This White Paper—first in a three-part series—focuses on FCA enforcement in the HCLS industry. We will examine the 2023 results, how they differ from previous years […]

By | May 3rd, 2024 ||

Closing The Gender Gap In Digital Health Technologies

From a smartphone microphone that can support an Alzheimer’s diagnosis to a wearable device that helps predict stroke, digital devices are poised to play a transformative role in the ability of healthcare stakeholders to collect key “endpoints”: criteria used by care providers to assess health and disease.

By capturing patient-generated health data right where patients live and work via wearables, apps, and sensors, digital health technologies (DHTs) are fostering earlier diagnoses, amassing information on treatment effectiveness and safety […]

By | May 1st, 2024 ||